Marc Taub, Ph.D., is Vice President of Technical Operations for Abbott’s diabetes care and biowearables businesses, overseeing global research and development, medical, and clinical affairs.
Based in Alameda, California, he has played a key role in pioneering biowearables like the FreeStyle Libre portfolio, world-leading glucose monitoring technology that has transformed care for people living with diabetes. This same technology powers Lingo, a consumer biowearable designed to help users track glucose for healthier habits and overall well-being.
Dr. Taub is also leading the development of Abbott’s first-of-its-kind dual glucose-ketone monitoring system for people with diabetes.
Dr. Taub is a published researcher and holder of numerous patents. He is a member of Abbott’s prestigious Volwiler Society, a Fellow of the American Institute for Medical and Biological Engineering, and a member of the National Academy of Engineering. He holds a bachelor’s degree from Brown University and a master’s and doctorate degrees from Stanford University.